Skip to main content

Garry A. Neil, M.D.

Equibles does not estimate personal net worth.

Get an email with a short summary when Celldex Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.

Get CLDX alerts

About Garry A. Neil, M.D.

Garry A. Neil, M.D. is recorded as Board Member at Celldex Therapeutics, Inc. (CLDX) since June 25, 2026. Celldex Therapeutics, Inc. reported in an 8-K filed June 26, 2026 that Garry A. Neil, M.D. was appointed Director, effective June 25, 2026. Celldex Therapeutics, Inc. reported in an 8-K filed June 6, 2025 that Garry A. Neil, M.D. was appointed director, effective June 5, 2025. Celldex Therapeutics, Inc. reported in an 8-K filed June 14, 2024 that Garry A. Neil, M.D. was appointed Director, effective June 13, 2024. Celldex Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Celldex Therapeutics, Inc. includes Anthony Marucci (CEO and Board Member), Anthony S. Marucci (CEO and Board Member), Harry H. Penner, Jr. (Chairman and Board Member) and 7 others.

“The stockholders elected the following individuals to serve on the Company's board of directors until the annual meeting of stockholders to be held in 2027.”
Celldex Therapeutics, Inc. Form 8-K, filed June 26, 2026 · Read the filing
“The stockholders elected the following individuals to serve on the Company’s board of directors until the annual meeting of stockholders to be held in 2026.”
Celldex Therapeutics, Inc. Form 8-K, filed June 6, 2025 · Read the filing

Affiliation history

Company network

Leadership on record at Celldex Therapeutics, Inc.

Recent activity